Eli Lilly's brand name for tirzepatide approved for weight management (and, more recently, for obstructive sleep apnea), given as a weekly injection. It shares its active ingredient with Mounjaro but carries the weight-loss label. In head-to-head trial data it produced greater average weight loss than Wegovy, making the two the headline rivalry in the category.
Related terms: Tirzepatide · Mounjaro · Wegovy · GIP receptor
See also: Wegovy vs. Zepbound